Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Codoxo Secures $35M Series C Funding Led by CVS Health Ventures
Series CVenture Capital

Codoxo Secures $35M Series C Funding Led by CVS Health Ventures

•December 17, 2025
•Dec 17, 2025
0

Participants

Codoxo

Codoxo

company

Echo Health Ventures

Echo Health Ventures

investor

Sands Capital

Sands Capital

investor

111 West Capital

111 West Capital

investor

Brewer Lane

Brewer Lane

investor

Wipro

Wipro

investor

450 Ventures

450 Ventures

investor

QED Investors

QED Investors

investor

Why It Matters

The infusion of strategic capital from a major health system and tech investors validates AI’s role in reducing claim errors, promising cost savings for payers and providers. It also accelerates Codoxo’s ability to scale its generative‑AI technology across the fragmented U.S. healthcare payment landscape.

Key Takeaways

  • •$35M Series C led by CVS Health Ventures
  • •Echo Health Ventures joins as new investor
  • •Total funding exceeds $75M for Codoxo
  • •AI-driven payment integrity market gaining traction
  • •Investors include major health insurers and tech funds

Pulse Analysis

Artificial intelligence is reshaping the economics of healthcare reimbursement, where claim errors and overpayments cost the U.S. system billions annually. Investors are increasingly targeting startups that can apply machine learning and generative AI to detect anomalies, automate audits, and enforce policy compliance. Codoxo’s recent financing reflects this trend, as capital flows toward solutions that promise measurable cost reductions and operational efficiency for insurers and providers alike.

Codoxo’s platform combines traditional rule‑based checks with generative AI models that can interpret unstructured clinical documentation, flagging inconsistencies in real time. By integrating directly with payer systems, the technology reduces manual review time and improves accuracy, delivering faster claim resolutions. Existing customers report lower denial rates and higher recovery of legitimate payments, positioning Codoxo as a differentiated player in a crowded market of payment integrity vendors.

The Series C round, anchored by CVS Health Ventures, not only provides growth capital but also grants Codoxo strategic access to one of the nation’s largest pharmacy networks. This partnership can accelerate pilot deployments, expand data assets, and enhance the platform’s learning algorithms. As more health insurers adopt AI‑centric workflows, Codoxo is poised to capture a larger share of the $30 billion payment integrity market, driving both revenue growth and industry‑wide adoption of advanced analytics.

Deal Summary

Codoxo, a Duluth‑based AI‑driven healthcare payment integrity platform, announced an oversubscribed Series C round that raised $35 million. The round was led by CVS Health Ventures with participation from Echo Health Ventures and existing backers including Sands Capital and Wipro Ventures, bringing total capital to over $75 million.

0

Comments

Want to join the conversation?

Loading comments...